Beta blockers reduce death risk in patients with heart failure initiating dialysis

Beta blockers may reduce mortality in patients with heart and kidney failure. Among 3,503 patients with heart failure initiating dialysis, 60.4% were receiving beta blockers at time of dialysis initiation; 455 died within 6 months. Compared to non-use, beta blocker use was associated with a 21% lower risk of death within 6 months of dialysis initiation after propensity score matching. These findings support use of beta blockers for patients with heart failure initiating dialysis.

###

ARTICLE TITLE: Beta Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis

AUTHORS: Hui Zhou, John J. Sim, Jiaxiao Shi, Sally F. Shaw, Ming-Sum Lee, Jonathan R. Neyer, Csaba P. Kovesdy, Kamyar Kalantar-Zadeh, and Steven J. Jacobsen

DOI: 10.1053/j.ajkd.2020.07.023

Under embargo until 3pm ET on September 30, 2020. Full text of article available by email from media contact.